Bcl-2 family of proteins regulates apoptosis by controlling mitochondrial membrane permeability. We have previously shown that the voltage-dependent anion channel (VDAC) plays a crucial role in apoptotic changes of the mitochondria and its activity is directly regulated by some Bcl-2 family members, including Bcl-2/Bcl-x L and Bax/Bak but not Bid. Here, we showed that in isolated mitochondria, Bim induced loss of membrane potential and cytochrome c release like Bax/Bak, with these changes being inhibited by an anti-VDAC antibody. In addition, microinjection of the anti-VDAC antibody significantly reduced Bim-induced apoptosis. Study using purified proteins indicated that Bim directly interacts with the VDAC. Immunoprecipitation analysis revealed that Bim interacts with the VDAC and the interaction is remarkably enhanced during apoptosis. An experiment using liposomes indicated that Bim enhanced VDAC activity, as did Bax/Bak. Furthermore, Bim (but not tBid) was able to induce apoptotic changes of yeast mitochondria in a VDACdependent manner, and also induced the lysis of red blood cells, with this effect being inhibited by the anti-VDAC antibody. These results indicate that Bim has an ability to activate directly the VDAC, which plays an important role in apoptosis of mammalian cells.
Introduction
Apoptosis or programmed cell death is a genetically regulated cellular suicide mechanism. It plays a critical role in normal development, maintenance of homeostasis, and elimination of unwanted cells (reviewed by Jacobson et al., 1997; Hengartner, 2000) . Numerous studies have shown that the mitochondria play a pivotal role in the apoptosis of mammalian cells. In response to various apoptotic stimuli, several apoptogenic factors such as cytochrome c and Smac/DIABLO are released from the intermembrane space of the mitochondria into the cytoplasm, which activate downstream destructive programs including caspase cascade (reviewed by Thornberry and Lazebnik, 1998; Wang, 2001) .
One of the best-characterized regulators of apoptosis is the Bcl-2 family of proteins, which comprises three subfamilies, (1) anti-apoptotic members, such as Bcl-2/ Bcl-x L , which usually possess the Bcl-2 homology (BH) 1, BH2, BH3, and BH4 domains; (2) pro-apoptotic members, including Bax/Bak, which have the BH1, BH2 and BH3 domains; and (3) BH3-only members like Bid/Bik that only possess the BH3 domain (reviewed by Adams and Cory, 1998; Tsujimoto and Shimizu, 2000a) . Many pro-apoptotic Bcl-2 members are normally localized in non-mitochondrial compartments and translocate to the mitochondria in response to apoptotic stimuli. The Bcl-2 family of proteins regulates mitochondrial membrane permeability; antiapoptotic members prevent the release of apoptogenic factors from the mitochondria, whereas pro-apoptotic members promote it (reviewed by Adams and Cory, 1998; Tsujimoto and Shimizu, 2000a) . It has recently been described that cells derived from bax/bak double knockout mice are resistant to various apoptotic stimuli including some BH3-only proteins Harris and Johnson, 2001; Zong et al., 2001) , leading to the notion that Bax and Bak mediate death signals from various BH3-only proteins. BH3-only proteins such as Bid and Bim (also known as Bod) have been shown to induce probably indirectly oligomerization of Bax and Bak on the mitochondria (Desagher et al., 1999; Eskes et al., 2000; Wei et al., 2000; Cheng et al., 2001) . Since oligomerized Bax has been shown to form a pore in liposomes that is permeable to proteins like cytochrome c but not much larger proteins (Saito et al., 2000) , oligomerized Bax or Bak might be at least partly responsible for release of mitochondrial apoptogenic factors. However, it has recently been reported that a pore that was identified by a patch-clump procedure on apoptotic mitochondria and believed to be responsible for the release of mitochondrial apoptogenic factors is substantially different from the Bax pore (Pavlov et al, 2001) . Furthermore, it is still to be debated whether or not activation of Bax/Bak by BH3-only proteins is sufficient to induce apoptosis. In addition to activating Bax/Bak, Bim might perform other function that is required for its pro-apoptotic activity.
We have previously reported that voltage-dependent anion channel (VDAC), the most abundant protein of the outer mitochondrial membrane, plays an important role in apoptosis, on the basis of the following observations: (1) anti-VDAC antibodies inhibit apoptosis induced by various apoptotic stimuli including Bax and staurosporine (Shimizu et al., 2001) , (2) Bax and Bak are unable to induce cytochrome c release from the mitochondria isolated from VDAC1-deficient yeast or mitochondria within such yeast, but this activity is restored by human VDAC1 (Shimizu et al., 1999 (Shimizu et al., , 2000c . We have also shown that some Bcl-2 family members directly bind to the VDAC (Narita et al., 1998; Shimizu et al., 1999 Shimizu et al., , 2000a Shimizu et al., ,b, 2001 Shimizu and Tsujimoto, 2000) and that Bax and the VDAC can form a large pore, which is permeable to cytochrome c, whereas Bcl-x L closes the VDAC (Shimizu et al., 1999 . On the basis of these results, we have proposed that the VDAC is an essential component of a pore that is responsible for release of mitochondrial apoptogenic factors . It has recently been reported that O 2 radical-induced cytochrome c release is mediated by a pore constituting of the VDAC (Madesh and Hajnoczky, 2001) .
In the present study, we attempted to characterize a role of Bim, one of the BH3-only proteins in apoptotic increase of mitochondrial membrane permeability. It has been reported that Bim is unleashed from the dynein motor complex to translocate to the mitochondria in response to apoptotic stimuli (Puthalakath et al., 1999) , and that lymphocytes from Bim-deficient mice are resistant to certain apoptotic stimuli such as cytokine deprivation, Ca 2+ ionophore, and taxol (Bouillet et al., 1999) . Here, we showed that the VDAC is directly involved in Bim-induced apoptosis and Bim has an ability to enhance VDAC activity via Figure 1 Bim induces Dc loss and cytochrome c release in isolated mitochondria. (a) Induction of Dc loss by Bim EL , but not Bim EL DGD. Isolated mitochondria (1 mg/ml) were incubated with 20 mg/ml of rHisBim EL , rHisBim EL DGD, or mock protein, and Dc was measured based on the rhodamine 123 (Rh123) uptake over 25 min. Data are representative of three independent experiments. When Dc decreased, Rh123 was released, resulting in an increase of the Rh123 intensity. (b) Characterization of Bim-induced Dc loss. Isolated mitochondria (1 mg/ml) were incubated with 20 mg/ml of rHisBim EL or rtBid, and Dc was measured from the Rh123 uptake at 25 min. Alternatively, isolated mitochondria (1 mg/ml) were incubated with 20 mg/ml of rHisBim EL in the presence of PT inhibitors (1 mM BK, 1 mM CsA, or 0.2 mM EGTA), and Dc was measured in the same way. Data are representative of two independent experiments. (c) Induction of cytochrome c release by Bim EL , but not Bim EL DGD. The same experiments as shown in (a) were carried out. After 30 min, samples were centrifuged, and aliquots of the supernatants were analysed by Western blotting using anti-cytochrome c antibody. 'Total' means an equivalent amount of mitochondria. Data are representative of two independent experiments. (d) Prevention of Bim-induced cytochrome c release by PT inhibitors. The same experiments as shown in (b) were carried out. After 30 min, samples were centrifuged, and aliquots of the supernatants were analysed by Western blotting using anti-cytochrome c antibody. 'Total' means an equivalent amount of mitochondria. Data are representative of three independent experiments direct interaction like Bax/Bak, and discussed a role of Bim-VDAC interaction in apoptotic cell death.
Results

Bim induces cytochrome c release and Dc loss in isolated mitochondria
A system with isolated mitochondria and recombinant proteins has proven very useful for studying the function of Bcl-2 family of proteins. We and others have shown that pro-apoptotic members such as Bax, Bak and tBid induce release of cytochrome c, which is inhibited by anti-apoptotic members (Ju¨rgensmeier et al., 1998; Narita et al., 1998; Finucane et al., 1999; Kluck et al., 1999; Pastorino et al., 1999; Shimizu et al., 1999; Shimizu and Tsujimoto, 2000; Wei et al., 2000) . We have also described that in addition to cytochrome c release, Bax and Bak can induce loss of the mitochondrial membrane potential (Dc) in a cyclosporin A (CsA)-sensitive manner, while Bid and Bik induce cytochrome c release without affecting Dc in isolated rat liver mitochondria under our experimental conditions (Narita et al., 1998; Shimizu and Tsujimoto, 2000) . To determine the effect of Bim on the mitochondria, we focused Bim EL , a major isoform of Bim (O'Connor et al., 1998; O'Reilly et al., 2000) . Isolated rat liver mitochondria were incubated with recombinant His-tagged Bim EL (rHisBim EL ), recombinant Bim EL DGD BH3 mutant (rHisBim EL DGD), which is a non-proapoptotic mutant (Chittenden et al., 1995) , or mock protein, and then Dc was measured using rhodamine 123, which accumulates in the mitochondria in a Dc-dependent manner, and cytochrome c release was assessed by Western blot analysis as described in Materials and methods. Addition of rHisBim EL , but not rHisBim EL DGD or mock protein, induced Dc loss (Figure 1a ,b) and cytochrome c release (Figure 1c ). Unlike Bim, recombinant truncated Bid (rtBid), another BH3-only protein, did not induced Dc loss (Figure 1b ), confirming our previous observation (Shimizu and Tsujimoto, 2000) . As shown in Figure 1b ,d, CsA, bongkrekic acid (BK), or chelation of Ca 2+ (using EGTA), all of which are known to prevent permeability transition (McEnery et al., 1992; Zoratti and Szabo, 1995; Nicolli et al., 1996; Beutner et al, 1998) , blocked both Bim-induced cytochrome c release and Dc loss, indicating that, Bim could induce the permeability transition like Bax/Bak (Ju¨rgensmeier et al., 1998; Narita et al., 1998; Pastorino et al., 1999; Shimizu and Tsujimoto, 2000) . These results demonstrated that rBim could induce Dc loss and cytochrome c release from isolated mitochondria in the same way as that of rBax/Bak.
VDAC plays an essential role in Bim-induced apoptotic changes of the mitochondria and apoptosis
Given that Bax-induced cytochrome c from mitochondria is dependent on the VDAC (Shimizu et al., 1999 (Shimizu et al., , 2001 , an essential role of the VDAC in Bim-induced apoptotic changes of the mitochondria was expected. As shown in Figure 2a ,b, an anti-VDAC antibody (Ab #25), which has previously been shown to inhibit the channel activity of the VDAC (Shimizu et al., Figure 2 Anti-VDAC antibody prevents Bim-induced apoptotic mitochondrial changes. (a) Inhibition of Bim-induced Dc loss by anti-VDAC antibody. Mitochondria (1 mg/ml) were incubated with 20 mg/ml of rHisBim EL in the presence of 0.3 mg/ml of an anti-VDAC antibody (aVDAC) or normal rabbit IgG (NRI), and Dc was measured from the rhodamine 123 (Rh123) uptake at 30 min. A protonophore, SF6847, was used to induce a complete loss of Dc. Data are representative of three independent experiments. The amount of the anti-VDAC antibody used was near the saturation level for the VDAC on the mitochondria, as previously described (Shimizu et al., 2001) . (b) Inhibition of Bim-induced cytochrome c release by the anti-VDAC antibody. The same experiment as shown in (a) was carried out. After incubation for 30 min, samples were centrifuged and aliquots of the supernatants were analysed by Western blotting. 'Total' means an equivalent amount of mitochondria. Data are representative of three independent experiments 2001), but not normal rabbit IgG (NRI) prevented rHisBim EL -induced Dc loss and cytochrome c release from isolated rat mitochondria, indicating that the VDAC has an essential role in Bim-induced apoptotic changes of the mitochondria.
We then attempted to confirm that the VDAC has an essential role in Bim-induced apoptosis of mammalian cells by microinjection experiments. First, rHisBim EL or rHisBim EL DGD with recombinant GFP (rGFP) was microinjected into the cytoplasm of HeLa The amount of the anti-VDAC antibody used was near the saturation level for the VDAC on the mitochondria, as previously described (Shimizu et al., 2001) . After 1 h, 0.15 mg/ml of rHisBim EL (left panel) or rtBid (right panel) was injected into the same cells with rGFP (2 mg/ml), and apoptosis was investigated based on changes of cell morphology. Data are representative of two independent experiments. (d) The same procedure shown in (c) was followed. Cell morphology was assessed at the indicated time by fluorescence microscopy. Bars, 20 mm cells and then cell death was assessed as described in Materials and methods. As shown in Figure 3a ,b, rHisBim EL induced apoptosis, but rHisBim EL DGD had little effect. Consistent results were also observed when Bim EL or Bim EL DGD cDNA was transfected into 293T cells (data not shown). As shown in Figure 3c ,d, when the anti-VDAC antibody or NRI (both were antisepticfree) was injected into the cytoplasm of HeLa cells, and then rHisBim EL or rtBid with rGFP was injected into the same cells 1 h later, the anti-VDAC antibody (but not NRI) caused a significant decrease of rHisBim ELinduced cell death. In contrast, the anti-VDAC antibody did not affect rtBid-induced apoptosis, confirming our previous observations (Shimizu et al., 2001) . These results indicated that the VDAC is essential for Biminduced apoptosis in mammalian cells. The conclusion is consistent with the previous observations that anti-VDAC antibodies prevent taxol-induced apoptosis (Shimizu et al., 2001) in which Bim has been shown to play an important role (Bouillet et al., 1999) .
Bim induces cytochrome c release in Bak-dependent andindependent manners
It has been reported that Bak is required for tBidinduced cytochrome c release in vitro (Wei et al., 2000) .
Since Bim is one of the BH3-only proteins, Bak might also be required for Bim activity. To determine whether Bak was involved in Bim-induced cytochrome c release, we used mitochondria prepared from bak +/ + and 7/7 mice. Bak deficiency was confirmed by Western blotting and genomic PCR ( Figure 4a and data not shown). As shown in Figure 4b , rHisBim EL induced cytochrome c release from both mitochondria although the amount of cytochrome c released from Bak-deficient mitochondria was greatly reduced. As we could not detect other Bcl-2 family proteins such as Bax, Bcl-2, and Bcl-x L in isolated mitochondria (data not shown), these results suggested that Bim induces cytochrome c release in both Bak-dependent and Bakindependent manners.
Bim induces apoptotic changes of yeast mitochondria which is dependent on the VDAC
To further characterize the activity of Bim with respect of interaction with other family members, we employed yeast mitochondria, because they do not possess Bcl-2 family members and response to some human and mouse Bcl-2 family members in a manner similar to mammalian mitochondria, providing a useful system for studying Bcl-2 family members in the absence of other family members or in the presence of specific family members. It has been reported that Bax induces cytochrome c release in yeast cells and in their isolated mitochondria (Manon et al., 1997; Priault et al., 1999; Shimizu et al., 1999 Shimizu et al., , 2000c and Bax-mediated cytochrome c release is inhibited by Bcl-2/Bcl-x L and by lack of VDAC1 (Manon et al., 1997; Shimizu et al., 1999 Shimizu et al., , 2000c . As shown in Figure 5a , surprisingly, rHisBim EL induced cytochrome c release not only from rat liver mitochondria but also from yeast mitochondria like Bax/Bak, whereas rtBid induced cytochrome c release from rat mitochondria, but not from yeast mitochondria. These data suggested that Bim was able to induce cytochrome c release independently of other Bcl-2 family members.
To investigate the requirement of the VDAC in Biminduced apoptotic changes of the mitochondria, we utilized three strains of yeast, which are m22-2 (DVDAC1), its parental strain (wild-type) and m22-2 harboring the human vdac1 gene (hVDAC1). Mitochondria isolated from these strains were incubated with rHisBim EL , rHisBim EL DGD, or mock protein, and then Dc loss and cytochrome c release were assessed. As shown in Figure 5b , rHisBim EL induced cytochrome c release from wild-type mitochondria, but not from DVDAC1 mitochondria. rHisBim EL induced cytochrome c release from mitochondria obtained from DVDAC1 yeast harboring human VDAC1 (Figure 5b ). Bim also induced Dc loss in yeast mitochondria in a VDAC-dependent manner like in rat mitochondria (Figure 5c ). These results indicated that Bim was able to induce cytochrome c in the absence of other Bcl-2 family proteins and that Bim-induced apoptotic mitochondrial changes were dependent on the VDAC in yeast mitochondria. Liver mitochondria from bak+/+ and bak7/7 mice were lysed and subjected to Western blotting using anti-Bak antibody. As a loding control, the same blot was re-probed with anticytochrome c antibody. (b) Bim can induce cytochrome c release from Bak-deficient mitochondria. Mitochondria isolated from bak+/+ and bak7/7 mice (1 mg/ml) were incubated with 10 or 20 mg/ml or rHisBim EL for 30 min at 258C. After incubation, samples were centrifuged and aliquots of the supernatants were analysed by Western blotting using anti-cytochrome c antibody. 'Total' means an equivalent amount of mitochondria. Data are representative of three independent experiments BH3-only protein Bim activates the VDAC T Sugiyama et al
Bim interacts with the VDAC
The essential role of VDAC in Bim-induced apoptosis and the ability of Bim to induce cytochrome c release from isolated yeast mitochondria, which was VDACdependent, raised the possibility that Bim has an ability to activate directly the VDAC like Bax/Bak. Therefore, we tested whether Bim could bind directly to the VDAC. VDAC protein purified from rat liver mitochondria was incubated with rHisBim EL or rHisBim EL DGD, and then a pull-down assay using nickel-nitrilotriacetic (Ni-NTA) agarose resin was performed as described in Materials and methods. As shown in Figure 6a , rHisBim EL bound to the VDAC, whereas rHisBim EL DGD showed very weak binding. Direct interaction of the VDAC with Bim EL was also confirmed by immunoprecipitation (Figure 6b ). These results indicated that Bim could interact directly with the VDAC.
To study the interaction of Bim and VDAC in cells during apoptosis, we used MCF-7 cells and Jurkat cells that have been shown to express Bim proteins (O'Reilly et al., 2000) . MCF-7 cells were treated with adriamycin (ADR), staurosporine (STS), or taxol for 12 h, and then were subjected to immunoprecipitation as described in Materials and methods. After an apoptotic stimulus, a large amount of Bim EL was co-immunoprecipitated with the VDAC, although the total amount of Bim EL remained unchanged (Figure 6c) . Similar results were obtained using Jurkat cells treated with Ca 2+ ionophore (A23187) or staurosporine (Figure 6d ). Although the interaction of Bim with the VDAC in cells was detected in the presence of as protein crosslinker, DTBP (Figure 6c,d ), Bim-VDAC interaction was also observed, to a slightly lesser extent, in the absence of the crosslinker (Figure 6e ). Because the level of Bim L expression was low compared with that of Bim EL in MCF-7 cells and Jurkat cell, it was unclear whether Bim L was bound to the VDAC. Therefore, we examined the interaction of exogenous Bim L with the VDAC. As shown in Figure  6f , Bim L was also co-immunoprecipitated with the VDAC when Bim L was overexpressed in HeLa cells. Since these experiments were conducted in the presence of the broad-spectrum caspase inhibitor Z-VAD-fmk at a concentration (100 mM) sufficient to block caspase activation, the interaction of Bim with the VDAC seems likely to be an initiating event in apoptotic signaling to the mitochondria rather than a consequence of apoptotic changes. We further examined whether other BH3-only proteins have an ability to associate with the VDAC. As shown in Figure 6g , neither tBid nor Bik bound to the VDAC. These results indicated that the interaction between Bim and the VDAC is not non-specific but physiologically important. 
Bim enhances VDAC activity
We have previously shown that Bax and Bak can enhance VDAC activity via direct interaction (Shimizu et al., 1999 Shimizu and Tsujimoto, 2000) . Since Bim was able to interact with the VDAC, we postulated that Bim could also enhance VDAC activity like Bax/Bak. To test this, we measured VDAC activity using VDAC liposomes, in which the VDAC purified from rat livers was incorporated into synthetic lipid membrane as described in Materials and methods. VDAC activity was assessed by incubating VDAC liposomes with or without rBim in the presence of 14 Csucrose and subsequently measuring the amount of sucrose taken into liposomes. As shown in Figure 7a , rHisBim EL (but not rHisBim EL DGD) enhanced sucrose uptake by VDAC liposomes, while it did not have any effect on plain liposomes. Unlike rHisBim EL , rtBid did not influence VDAC activity (Figure 7a ), confirming our previous observation (Shimizu and Tsujimoto, 2000) . As shown in Figure 7b , the enhancement of VDAC activity by rHisBim EL was blocked in the presence of anti-VDAC antibody, but not NRI. Note that the enhancement of VDAC activity by Bim was comparable to that by Bax (Figure 7c ). These results indicate that Bim interacts directly and functionally with the VDAC like Bax/Bak.
Bim induces red blood cell lysis which is dependent on the VDAC
Despite a non-physiological system, red blood cells (RBCs) seem to be a unique system for characterizing a biochemical activity of Bcl-2 family members, because it has been reported that rBax induces the lysis of RBCs (Antonsson et al., 1997) , which is dependent on the surface VDAC (Shimizu et al., 2001) . Since Bim directly bound to and enhanced the activity of the VDAC, we attempted to confirm the activity of Bim on the VDAC using the RBC system. As shown in Figure 8a (top panel), both rHisBim EL and rHisBim L induced hemolysis, whereas mock protein and rHisBim EL DGD did not. Addition of rtBid did not cause hemolysis (Figure 8a , top panel) although it had a comparable cytochrome c-releasing activity (Figure 8a, bottom panel) . As shown in Figure  8b , the anti-VDAC antibody (but not NRI), which inhibited Bax-induced hemolysis (Shimizu et al., 2001) , inhibited Bim L -induced hemolysis. These results highlighted the concept that Bim has an ability to increase membrane permeability by targeting the VDAC, similarly to Bax.
Discussion
We have previously reported that Bax and Bak, but not tBid and Bik, can directly and functionally interact with the VDAC and form a cytochrome c-conducting pore, whereas Bcl-x L closes the VDAC, thereby inhibiting cytochrome c release (Narita et al., 1998; Shimizu et al., 1999 Shimizu et al., , 2000c Shimizu and Tsujimoto, 2000) . We have also shown that Bax-induced mitochondrial changes and apoptotic cell death are dependent on VDAC activity (Shimizu et al., 2001) . Here, we showed that both Bim-induced cytochrome c release from isolated mitochondria and Bim-induced apoptotic cell death were considerably inhibited by an anti-VDAC antibody. These findings are consistent with the previous observations that Bax or Bak is required for the pro-apoptotic activity of Bim Harris and Johnson, 2001; Wei et al., 2001; Zong et al., 2001) , and Bax/Bak-induced apoptotic changes are dependent on VDAC (Shimizu et al., 2001) . However, we have also shown that Bim has an ability to interact directly with the VDAC and enhance VDAC activity in a similar manner to Bax/Bak ( Figure  9 ). This observation is consistent with our observation with the Bak+/+ and Bak7/7 mitochondria, that Bim induced cytochrome c release by both Bakdependent and Bak-independent mechanisms. The ability of Bim to activate the VDAC is supported by the findings that like Bax/Bak, Bim (but not tBid) induced apoptotic changes of yeast mitochondria that lack Bcl-2 family members, and that Bim (but not tBid) induced lysis of RBCs that is VDAC-dependent. However, our current finding of independent signaling from Bim and Bax/Bak to the VDAC is apparently inconsistent with a linear cascade model with signaling from BH3-only proteins such as Bid to multi-domain member Bax or Bak. There may be several explanations including the following. The study with bax/bak double-knockout cells indicates only that Bax/Bak is required for Bim-induced apoptosis but does not prove that Bim-induced activation of Bax/Bak is sufficient for apoptosis. Therefore, VDAC activation not only by Bax/Bak but also by Bim may be required for Biminduced apoptosis. It might also be that Bim enhances Bax/Bak activity through the VDAC. It has been reported that Bim, which does not interact with Bax/ Bak, induces oligomerization of Bax/Bak . Therefore, VDAC-mediated mitochondrial change by Bim may induce Bax/Bak oligomerization on the mitochondria. Alternatively, Bim-induced activation of VDAC might be sufficient for inducing apoptosis of certain cell types. Another possibility is that since susceptibility of a cell to death is regulated by the balance between anti-apoptotic and proapoptotic members of the Bcl-2 family and the balance is disturbed by Bax/Bak-deficiency to anti-apoptotic dominance, such unbalance makes a cell resistant to a variety of death signals. To distinguish between these possibilities, further investigation will be required.
We believe that the Bim -VDAC interaction is physiologically significant, because under the same conditions, we have not detected interaction between the VDAC and tBid or Bik. A physiological role of the Bim -VDAC interaction in apoptosis is also supported by the observation that Bim -VDAC interaction markedly increased during apoptosis triggered by several different agents and in different cell lines. In living cells, only a very small amount of Bim interacted Figure 6 Bim interacts with the VDAC. (a and b) Direct interaction of rHisBim EL with purified VDAC. (a) Purified VDAC protein (10 mg) was incubated with 5 mg of rHisBim EL , rHisBim EL DGD, or mock protein for 12 h at 48C. Then Ni-NTA agarose resin was added for 3 h at 48C and collected by centrifugation, after which bound VDAC was analysed by Western blotting using anti-VDAC antibody. 'Total' means 1/10 of the purified VDAC used in the experiments. (b) Purified VDAC (10 mg) and rHisBim EL (10 mg) were incubated for 12 h at 48C, and were subjected immunoprecipitated using anti-VDAC antibody (aVDAC) or normal mouse IgG (NMI). Then the immune complexes were analysed by Western blotting using anti-His tag antibody. 'Total' means 1/10 of the rHisBim EL used in the experiments. (c,d, and e) Interaction between endogenous Bim and VDAC. (c) MCF-7 cells were exposed to 10 mM adriamycin (ADR), 0.5 mM staurosporine (STS), 0.1 mM taxol, or 0.1% DMSO (control) in the presence of 100 mM Z-VAD-fmk for 12 h, and then were treated with 5 mM chemical crosslinker DTBP. Cell lysates were subjected to immunoprecipitation with anti-VDAC antibody (aVDAC) or normal mouse IgG (NMI). Then the immune complexes were analysed by Western blotting using anti-Bim antibody. 'Total' means 1/10 of the cell lysates used for the experiments. (d) Jurkat cells were treated with 10 mM A23187 or 0.5 mM staurosporine (STS), or 0.1% DMSO (control) in the presence of 100 mM Z-VAD-fmk for 12 h and cell lysates were subjected to immunoprecipitation as described in (c). 'Total' means 1/10 of the cell lysates used for the experiments. (e) Jurkat cells were treated with 2 mM staurosporine for 6 h in the presence of 100 mM Z-VAD-fmk. Cell lysates were prepared with or without DTBP treatment and subjected to immunoprecipitation. 'Total' means 1/10 of the cell lysates used for the experiments. (f) Interaction of exogenous Bim L with the endogenous VDAC in HeLa cells. HeLa cells were transfected with pCAGGS-Bim L and were subjected to immunoprecipitation as described in (c). 'Total' means 1/10 of cell lysates used for the experiments. (g) Inability of tBid and Bik to interact with the VDAC. Jurkat cells were treated with 2 mM staurosporine for 6 h in the absence of Z-VAD-fmk. Cell lysates were prepared with DTBP treatment and subjected to immunoprecipitation. 'Total' means an equivalent amount of the cell lysates used for the experiments with the VDAC, probably because Bim and the VDAC are localized in different subcellular compartments, microtubule and mitochondria, respectively. In response to apoptotic stimulation, Bim translocates to the mitochondria (Puthalakath et al., 1999) , and we found that a large fraction of Bim (up to 30 -40%) became associated with the VDAC. The observations that the majority of Bim interacted with the VDAC during apoptosis and the interaction was not inhibited by a pan-caspase inhibitor, strongly suggest an important role of Bim-VDAC interaction in triggering apoptosis.
We have previously shown that a BH3 mutant of Bax binds to but does not activate the VDAC. In this study, we showed that a BH3 mutant of Bim binds only weakly to the VDAC, indicating that the BH3-domain is important for the interaction with and/or activation of the VDAC. Although it is not determined whether Bim and Bax/Bak bind to the identical or overlapping region of the VDAC, Bim and Bax do not compete in the induction of cytochrome c release in vitro (our unpublished observation). The molecular structure of the cytochrome c-conducting VDAC/Bax (Bim) pore is to be elucidated. It could be a hybrid channel consisting of VDAC and Bax (or Bim). However, a recent observation that VDAC itself forms a cytochrome c-permeable pore in response to O 2 radicals (Madesh and Hajnoczky, 2001), may imply that VDAC itself possesses an ability to form a large pore, which Bax, and Bim might trigger or potentiate. Structural studies of the VDAC in the presence of Bcl-2 family members will be necessary for understanding the detailed mechanism how Bcl-2 family members modulate the VDAC.
Materials and methods
Chemicals
An anti-human Bim polyclonal antibody (IN) , that reacted with all Bim isoforms was purchased from Millennium Biotechnology. An anti-human VDAC polyclonal antibody (Ab#25) was used that recognized the cytoplasmic region of VDAC1 (amino acids 104 -120), as described previously (Shimizu et al., 2001 ). An anti-human VDAC monoclonal antibody (31HL) was purchased from Calbiochem, and an antipigeon cytochrome c monoclonal antibody (7316A) that crossreacted with rat cytochrome c was obtained from BD Pharmingen. The anti-His tag monoclonal antibody and antiBid polyclonal antibody were purchased from Qiagen and Biosource international, respectively, while an anti-yeast cytochrome c polyclonal antibody was kindly provided by Dr G Schatz (Swiss Science and Technology Council, Switzerland). An anti-Bik polyclonal antibody (FL160) was obtained from Santa Cruz. Bongkrekic acid (BK) and SF6847 were kindly provided by Drs H Terada and Y Shinohara (Tokushima University, Japan). Dimethyl-3, 3'-dithiobispropionimidate (2HCl) (DTBP) was obtained from Pierce. Fatty acid free-BSA was obtained from Sigma, A23187 was purchased from Nacalai Tesque, Inc., and [ 14 C]-sucrose was purchased from 
Plasmid construction
cDNAs for human Bim EL and Bim L were amplified from a human thymus cDNA library using specific primers. cDNA for a Bim EL DGD mutant (lacking G156 and D157 in the BH3 domain) was generated by PCR-based mutagenesis. These cDNAs were inserted into a mammalian expression vector pCAGGS (Niwa et al., 1991) and a bacterial expression vector pRSET B (Invitrogen). Human vdac1 cDNA was cloned into yeast expression vector pBDL. The authenticity of all constructs was confirmed by DNA sequencing.
Protein purification
Human Bim EL , Bim EL DGD, Bim L and Bax were produced as His-tagged proteins in E. coli XL-1 Blue strain using the Xpress System (Invitrogen). His-tagged Bim L and Bax were purified on nickel-nitrilotriacetic (Ni-NTA) agarose resin (Qiagen) under non-denaturing conditions, whereas Bim EL and Bim EL DGD were purified on Ni-NTA agarose resin under denaturing conditions according to the supplier's protocol. Renaturation of Bim EL and Bim EL DGD was carried out by dialysis against renaturing buffer [20 mM potassium HEPES (pH 7.4), 150 mM NaCl, 1 mM DTT, and 0.5% CHAPS] for 24 h at 48C. Truncated human Bid (tBid) was produced as a glutathione S-transferase (GST) fusion protein in E. coli BL21-RIL (Stratagene) using the pGEX-6P1 vector (Amersham Pharmacia Biotech). GST-tBid was purified on glutathione-sepharose 4B (Amersham Pharmacia Biotech) and then tBid was released from GST by cleavage with PreScission protease (Amersham Pharmacia Biotech). The purity of Bim EL , Bim EL DGD, Bim L , Bax, and tBid was roughly 80%. Finally, all purified proteins were dissolved in 20 mM potassium HEPES (pH 7.4). Rat liver VDAC was purified as described previously (De Pinto et al., 1987) . The purity of VDAC was shown to be 495%.
Preparation of mitochondria
Rat and mouse liver mitochondria were isolated as described previously (De Pinto et al, 1987) . Briefly, livers, from male Donryu rats, wild-type mice, and bak7/7 mice were homogenized with a glass-Teflon Potter homogenizer. Mitochondria were isolated in 0.3 M mannitol with 10 mM potassium HEPES (pH 7.4), 0.2 mM EDTA, and 0.1% fatty acid-free BSA (MT-1 medium). Then the mitochondria were washed twice and resuspended in the same medium without EDTA (MT-2 medium).
For the isolation of yeast mitochondria, yeast cells were grown in non-fermenting, glycerol-based medium and spheroplasts were obtained using zymolyase 20T. Spheroplasts were suspended in 0.6 M mannitol with 10 mM Tris-HCl (pH 7.4), 0.1% fatty acid-free BSA, and 1 mM PMSF (yMT-1 medium), and then were homogenized with a tight fitting homogenizer. The isolated mitochondria were washed twice and resuspended in the same medium without PMSF (yMT-2 medium).
Measurement of mitochondrial Dc and cytochrome c release
Isolated rat mitochondria (1 mg protein/ml) were incubated at 258C in MT-2 medium plus 0.1 mM potassium phosphate and 4.2 mM succinate (MT-3 medium). Isolated yeast mitochondria (0.5 mg protein/ml) were incubated at 258C in yMT-2 medium plus 1 mM potassium phosphate and 4.2 mM succinate (yMT-3 medium). Dc was assessed by measuring the Dc-dependent uptake of rhodamine 123 using a Hitachi F-4500 or CytoFluor spectrophotometer (Applied Biosystems), as described previously (Narita et al., 1998) .
For the cytochrome c release assay, rHisBim EL , rHisBim EL DGD, rHisBim L , rtBid, or mock protein was incubated with isolated mitochondria (1 mg/ml) for 30 min at 258C in 100 ml of MT-3 or yMT-3 medium and the supernatants were separated by centrifugation. The aliquots were then subjected to Western blot analysis using anti-cytochrome c antibody to measure cytochrome c release from the mitochondria. The protein concentrations used for measurement of mitochondrial Dc and cytochrome c release are shown in the figure legends.
Cell culture and yeast strains
Human cell lines, HeLa (D98/AH 2 ) and Jurkat, were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). Human cell lines, 293T and MCF-7 were grown in DMEM supplemented with 10% FBS. Transfection was performed using FuGENE6 (Roche Diagnostics) according to the supplier's protocol.
A VDAC1-deficient yeast (S. cerevisiae) strain, DVDAC1 (m22-2, MATa lys2 his4 trp1 ade2 por1::LEU2 ura3) and its parent strain (m3, MATa lys2 his4 trp1 ade2 leu2 ura3) were kindly provided by Dr M Forte (Vollum Institute for Advanced Biomedical Research, USA). A human VDAC1-expressing DVDAC1 yeast strain was produced by transformation with a human vdac1 expression vector (Shimizu et al., 1999) .
Microinjection
Microinjection experiments were performed using a micromanipulator (Narishige), essentially as described previously (Matsuoka et al., 1994; Hieda et al., 1999; Shimizu et al., 2001) . In brief, rHisBim EL or rHisBim EL DGD with rGFP was injected into the cytoplasm of HeLa cells. In some experiments, 10 mg/ml of anti-VDAC antibody or NRI (antiseptic-free) was injected into the cytoplasm of HeLa cells, followed by the injection of rHisBim EL with rGFP 1 h later. The concentrations of proteins used for microinjection are shown in the figure legends. Cell death was assessed on the basis of cell morphology, apoptotic chromatin condensation, and nuclear fragmentation after staining with Hoechst33342.
In vitro binding assay and immunoprecipitation
To detect binding between the purified VDAC and recombinant proteins, the VDAC protein (10 mg) was incubated for 12 h at 48C with either His-tagged Bim EL (5 mg), His-tagged Bim EL DGD (5 mg), or mock protein (5 mg) in 100 ml of lysis buffer (50 mM Tris-HCl (pH 7.5), 142.5 mM KCl, 5 mM MgCl 2 , 1 mM EGTA, and 0.2% NP-40). Then these proteins were subjected to immunoprecipitation. Alternatively, these proteins were incubated for 3 h at 48C with Ni-NTA agarose resin. After brief centrifugation, the resin was washed three times with lysis buffer and proteins were resuspended in sample buffer for SDS -PAGE.
To examine the interactions between endogenous Bim EL and the VDAC, either MCF-7 or Jurkat cells were treated with 10 mM adriamycin, 0.5 mM staurosporine, 0.1 mM taxol, or 10 mM A23187 in the presence of 100 mM Z-VAD-fmk. After 12 h, the cells were washed with PBS and incubated with 5 mM chemical crosslinker dimethyl-3, 3'-dithiobispropionimidate (2HCl) (DTBP) in PBS for 30 min. In some experiments, the crosslinker step was omitted. Then the cells were lysed, sonicated, and subjected to immunoprecipitation, as described previously (Narita et al., 1998) . To compare the interactions between the VDAC and endogenous tBid, or Bik, Jurkat cells were treated with 2 mM staurosporine for 6 h without Z-VAD-fmk (because Z-VAD-fmk prevents Bid cleavage). After DTBP treatment, the cells were lysed and subjected to immunoprecipitation. To test for interactions between exogenous Bim L and the endogenous VDAC, HeLa cells were transfected with pCAGGS-Bim L for 24 h. Then the cells were treated with 5 mM DTBP and subjected to immunoprecipitation as described above.
VDAC liposomes
Plain and VDAC liposomes were prepared as described previously (Shimizu et al., 1999) . VDAC activity was measured by assessing [ 14 C]-sucrose uptake, as described elsewhere (Shimizu et al., 1999) . In brief, 20 ml of liposomes were incubated for 5 min at 258C with 2 mCi of [
14 C]-sucrose in the presence of 30 mg/ml of rHisBim EL , rHisBim EL DGD, rHisBim L , rtBid, or mock protein. In some experiments, VDAC liposomes were pre-treated with 0.2 mg/ml of anti-VDAC antibody, or normal rabbit IgG (NRI) for 3 min, and then were incubated with 30 mg/ml of rHisBim EL and [
14 C]-sucrose for 5 min. Subsequently, VDAC liposomes were collected and [
14 C]-sucrose incorporation into the liposomes was measured with a g-scintillation counter (model 1414; Wallac).
Lysis of red blood cells
Red blood cells (RBCs) were obtained from a healthy donor who gave informed consent, and 7.5% (vol/vol) RBCs in 0.9% NaCl were treated with 0.25 mg/ml of rHisBim EL , rHisBim L , rHisBim EL DGD, rtBid, or mock protein. In another experiment, 2.5% (vol/vol) RBCs in 0.9% NaCl were incubated for 1 h at 308C with 0.25 mg/ml of rHisBim L in the presence of 0.8 mg/ml of anti-VDAC antibody or NRI. After incubation, the RBCs were spun, and hemoglobin release was determined by measuring the absorbance at 543 nm (the isospecific point of reduced and oxidized hemoglobin) using a spectrophotometer (UV-160A; Shimazu).
Abbreviations BH, Bcl-2 homology; BK, bongkrekic acid; CsA, cyclosporin A; cyt. c, cytochrome c; Dc, mitochondrial membrane potential; NRI, normal rabbit IgG; PT, permeability transition; RBCs, red blood cells; Rh123, rhodamine 123; tBid, truncated Bid; VDAC, voltage-dependent anion channel.
